KENACORT Side Effects

6971252-9 | Conjunctival Haemorrhage, Scleral Thinning
on Sep 02, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with scleritis and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival haemorrhage, scleral thinning. Kenacort dosage: 1 Df: 2-4mg.

6971251-7 | Scleral Thinning
Patient was taking Kenacort (View Usage). Patient had the following side effects: scleral thinning on Sep 02, 2010 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with scleritis and. Kenacort dosage: 1 Df: 2-4mg.

6971250-5 | Scleral Thinning
Adverse event was reported on Sep 02, 2010 by a Male patient taking Kenacort (View Usage) (Dosage: 1 Df: 2-4mg) was diagnosed with scleritis and. Location: JAPAN , 62 years of age, After Kenacort was administered, patient had the following side effects: scleral thinning.

6971249-9 | Scleral Thinning
on Sep 02, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with scleritis and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: scleral thinning. Kenacort dosage: 1 Df: 2.4mg-8mg In Total.


6970088-2 | Conjunctival Haemorrhage
on Sep 02, 2010 Male patient from JAPAN , 21 years of age, was diagnosed with scleritis and was treated with Kenacort (View Usage). Patient had the following side effects: conjunctival haemorrhage. Kenacort dosage: 1 Df: 2-4mg.

6927967-1 | Adrenal Insufficiency, Dermatitis, Nosophobia, Osteoporosis
Patient was taking Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: adrenal insufficiency, dermatitis, nosophobia, osteoporosis (What is osteoporosis?) on Aug 13, 2010 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with back pain (What is back pain?), sialoadenitis and. Kenacort dosage: . During the same period patient was treated with ROVAMYCINE (View Rovamycine Review and Rovamycine Label ), OFLOCET (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

6922739-6 | Synovitis, Tendon Rupture
Adverse event was reported on Aug 06, 2010 by a Male patient taking Kenacort (View Usage) (Dosage: Route-intra-tendon Sheath 20mg Taken Twice And Three Times At Other Clinic) was diagnosed with trigger finger, pain (What is pain?), tenosynovitis stenosans and. Location: JAPAN , 37 years of age, weighting 156.5 lb, Patient experienced the following unwanted or unexpected effects: synovitis, tendon rupture. During the same period patient was treated with XYLOCAINE (Inj 1percent) (View Xylocaine Review and Xylocaine Label ).

6920613-2 | Atrophy, Paraesthesia, Sensation Of Heaviness, Throat Tightness
on Jul 30, 2010 Female patient from FRANCE , 52 years of age, was treated with Kenacort (View Usage). Patient had the following side effects: atrophy, paraesthesia, sensation of heaviness, throat tightness. Kenacort dosage: 1df=two Injections 1st Inj One Week After Thyroid Ablation + 2nd Inj Four Weeks Later..

6918789-6 | Atrophy, Paraesthesia, Sensation Of Heaviness, Throat Tightness
on Jul 30, 2010 Female patient from FRANCE , 52 years of age, was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: atrophy, paraesthesia, sensation of heaviness, throat tightness. Kenacort dosage: 1df=two Injections 1st Inj One Week After Thyroid Ablation + 2nd Inj Four Weeks Later..

6914819-6 | Conjunctival Haemorrhage, Scleral Thinning
Patient was taking Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival haemorrhage, scleral thinning on Jul 28, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with scleritis and. Kenacort dosage: 1 Df: 2-4mg.

6914817-2 | Conjunctival Haemorrhage
Adverse event was reported on Jul 28, 2010 by a Male patient taking Kenacort (View Usage) (Dosage: 1 Df: 2-4mg) was diagnosed with scleritis and. Location: JAPAN , 21 years of age, Patient had the following side effects: conjunctival haemorrhage.

6914811-1 | Scleral Thinning
on Jul 28, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with scleritis and was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: scleral thinning. Kenacort dosage: 1 Df: 2-4mg.

6914804-4 | Scleral Thinning
on Jul 28, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with scleritis and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: scleral thinning. Kenacort dosage: 1 Df: 2-4mg.

6914794-4 | Scleral Thinning
Patient was taking Kenacort (View Usage). Patient had the following side effects: scleral thinning on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with scleritis and. Kenacort dosage: 1 Df: 2.4mg-8mg In Total.

6913979-0 | Atrophy, Paraesthesia, Sensation Of Heaviness, Throat Tightness
Adverse event was reported on Jul 30, 2010 by a Female patient taking Kenacort (View Usage) (Dosage: 1df=two Injections 1st Inj One Week After Thyroid Ablation + 2nd Inj Four Weeks Later.) . Location: FRANCE , 52 years of age, After Kenacort was administered, patient had the following side effects: atrophy, paraesthesia, sensation of heaviness, throat tightness.

6786637-3 | Joint Dislocation, Ligament Rupture, Muscle Atrophy, Skin Depigmentation
on Jun 14, 2010 Female patient from CONGO, THE DEMOCRATIC REPUBLIC OF THE , 17 years of age, was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: joint dislocation, ligament rupture, muscle atrophy, skin depigmentation. Kenacort dosage: Received 2 Local Inj..

6749854-4 | Altered State Of Consciousness, Convulsion
on May 21, 2010 Female patient from JAPAN , 24 years of age, was diagnosed with keloid scar and was treated with Kenacort (View Usage). Patient had the following side effects: altered state of consciousness, convulsion. Kenacort dosage: Till 21may2010: Three Times. On 21may2010: Received Kenacort A 0.1 Cc On Back Roa: Intracutaneous.

6748118-2 | Synovitis, Tendon Rupture
Patient was taking Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: synovitis, tendon rupture on May 24, 2010 from JAPAN Additional patient health information: Male patient , 37 years of age, was diagnosed with trigger finger, pain (What is pain?) and. Kenacort dosage: Route-intra-tendon Sheath 20mg Taken Twice And Three Times At Other Clinic.

6740354-4 | Altered State Of Consciousness, Convulsion
Adverse event was reported on May 21, 2010 by a Female patient taking Kenacort (View Usage) (Dosage: Till 21may2010: Three Times. On 21may2010: Received Kenacort A 0.1 Cc On Back Roa: Intracutaneous) was diagnosed with keloid scar and. Location: JAPAN , 24 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, convulsion.

6727491-5 | Synovitis, Tendon Rupture
on May 06, 2010 Male patient from JAPAN , 37 years of age, was diagnosed with trigger finger, pain (What is pain?) and was treated with Kenacort (View Usage). Patient had the following side effects: synovitis, tendon rupture. Kenacort dosage: Route-intra-tendon Sheath.

6712984-7 | Haemarthrosis
on May 03, 2010 Male patient from FRANCE , 67 years of age, was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: haemarthrosis. Kenacort dosage: 1df=80mg/2ml. During the same period patient was treated with PERFALGAN (View Perfalgan Review and Perfalgan Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), ULTRAVIST 150 (Ultravist 370) (View Ultravist 150 Review and Ultravist 150 Label ), PLAVIX (1tab Orally.) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6667680-1 | Pain, Skin Atrophy, Skin Necrosis
Patient was taking Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?), skin atrophy, skin necrosis on Mar 30, 2010 from FRANCE Additional patient health information: Female patient , 54 years of age, was diagnosed with hypersensitivity, urticaria, urticaria chronic, venous insufficiency and. Kenacort dosage: . During the same period patient was treated with XYZAL (1df- 1 Tabs) (View Xyzal Review and Xyzal Label ), ATARAX (View Atarax Review and Atarax Label ), GINKOR FORT (2df- 2 Caps) (View Ginkor Fort Review and Ginkor Fort Label ).

6594272-5 | Haemarthrosis, Injection Site Pain
Adverse event was reported on Feb 12, 2010 by a Female patient taking Kenacort (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, Patient had the following side effects: haemarthrosis, injection site pain.

6572387-5 | Atrophy, Pain, Skin Necrosis
on Feb 01, 2010 Female patient from FRANCE , 54 years of age, was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: atrophy, pain (What is pain?), skin necrosis. Kenacort dosage: .

6528611-8 | Arthritis, Arthritis Bacterial, Joint Range Of Motion Decreased, Osteonecrosis
on Dec 25, 2009 Male patient from JAPAN , 43 years of age, was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), arthritis bacterial, joint range of motion decreased, osteonecrosis (What is osteonecrosis?). Kenacort dosage: .

6521531-4 | Arthritis, Arthritis Bacterial, Joint Range Of Motion Decreased, Osteonecrosis
Patient was taking Kenacort (View Usage). Patient had the following side effects: arthritis (What is arthritis?), arthritis bacterial, joint range of motion decreased, osteonecrosis (What is osteonecrosis?) on Dec 21, 2009 from JAPAN Additional patient health information: Male patient , 43 years of age, . Kenacort dosage: .

6518933-9 | Anaphylactic Shock, Cellulitis Orbital, Necrotising Scleritis
Adverse event was reported on Dec 16, 2009 by a Female patient taking Kenacort (View Usage) (Dosage: ) was diagnosed with macular oedema and. Location: JAPAN , 77 years of age, After Kenacort was administered, patient had the following side effects: anaphylactic shock, cellulitis orbital, necrotising scleritis. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6507560-5 | Anaphylactic Shock, Cellulitis Orbital, Necrotising Scleritis
on Dec 09, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with macular oedema and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cellulitis orbital, necrotising scleritis. Kenacort dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6442889-0 | Intraocular Pressure Increased, Macular Rupture, Retinal Detachment
on Nov 03, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with keratitis and was treated with Kenacort (View Usage). Patient had the following side effects: intraocular pressure increased, macular rupture, retinal detachment. Kenacort dosage: .

6406914-5 | Injection Site Extravasation, Intraocular Pressure Decreased, Staphyloma, Visual Acuity Reduced
Patient was taking Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: injection site extravasation, intraocular pressure decreased, staphyloma, visual acuity reduced on Oct 12, 2009 from GREECE Additional patient health information: Female patient , 65 years of age, was diagnosed with diabetic retinal oedema and. Kenacort dosage: .

6394883-6 | Staphyloma
Adverse event was reported on Oct 05, 2009 by a Female patient taking Kenacort (View Usage) (Dosage: ) was diagnosed with diabetic retinal oedema and. Location: GREECE , 65 years of age, Patient experienced the following unwanted or unexpected effects: staphyloma.

6253245-2 | Confusional State, Eye Irritation, Gastrointestinal Disorder, Tremor
on Jun 26, 2009 Male patient from FRANCE , 35 years of age, was diagnosed with prophylaxis and was treated with Kenacort (View Usage). Patient had the following side effects: confusional state, eye irritation, gastrointestinal disorder, tremor. Kenacort dosage: . Patient was hospitalized.

6134597-0 | Joint Instability
on Mar 25, 2009 Female patient from JAPAN , 42 years of age, was diagnosed with epicondylitis and was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: joint instability. Kenacort dosage: 80 Mg Locally Injected.

6122572-1 | Crystal Arthropathy
Patient was taking Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: crystal arthropathy on Mar 13, 2009 from JAPAN Additional patient health information: Female patient , 52 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Kenacort dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ).

6114510-2 | Retinal Vasculitis
Adverse event was reported on Mar 09, 2009 by a Female patient taking Kenacort (View Usage) (Dosage: ) was diagnosed with eye operation and. Location: JAPAN , 53 years of age, Patient had the following side effects: retinal vasculitis. Patient was hospitalized.

6111630-3 | Depression, Muscle Atrophy, Muscle Injury, Sleep Disorder
on Mar 10, 2009 Female patient from FRANCE , 35 years of age, weighting 105.8 lb, was diagnosed with hypersensitivity and was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: depression (What is depression?), muscle atrophy, muscle injury, sleep disorder (What is sleep disorder?). Kenacort dosage: Kenacort 80 Mg - 1 Injection/year For 3-4 Years,total-4inj,last Dose Given In Mar08..

6103102-7 | Joint Instability
on Mar 03, 2009 Female patient from JAPAN , 42 years of age, was diagnosed with epicondylitis and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: joint instability. Kenacort dosage: 80 Mg Locally Injected.

6084063-6 | Depression, Muscle Atrophy, Muscle Injury, Sleep Disorder
Patient was taking Kenacort (View Usage). Patient had the following side effects: depression (What is depression?), muscle atrophy, muscle injury, sleep disorder (What is sleep disorder?) on Feb 18, 2009 from FRANCE Additional patient health information: Female patient , 35 years of age, weighting 103.6 lb, . Kenacort dosage: Kenacort 80 Mg - 1 Injection/year For 3-4 Years.

6079727-4 | Joint Instability
Adverse event was reported on Feb 12, 2009 by a Female patient taking Kenacort (View Usage) (Dosage: 80 Mg Locally Injected) was diagnosed with epicondylitis and. Location: JAPAN , 42 years of age, After Kenacort was administered, patient had the following side effects: joint instability.

6071674-7 | Lichen Planus, Lichen Striatus
on Feb 06, 2009 Male patient from JAPAN , 21 years of age, was diagnosed with alopecia areata and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: lichen planus, lichen striatus. Kenacort dosage: .

6054720-6 | Lichen Planus, Lichen Striatus
on Jan 19, 2009 Male patient from JAPAN , 20 years of age, was diagnosed with alopecia areata and was treated with Kenacort (View Usage). Patient had the following side effects: lichen planus, lichen striatus. Kenacort dosage: .

6052745-8 | Retinal Vascular Disorder
Patient was taking Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: retinal vascular disorder on Jan 21, 2009 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with eye operation and. Kenacort dosage: .

6048368-7 | Arthritis, Fasciitis
Adverse event was reported on Jan 19, 2009 by a Male patient taking Kenacort (View Usage) (Dosage: Kenacort Retard 80 Mg/2ml 80 Mg Single Administration) was diagnosed with hypersensitivity and. Location: FRANCE , 68 years of age, Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), fasciitis. Patient was hospitalized.

6048253-0 | Lichen Planus, Lichen Striatus
on Jan 19, 2009 Male patient from JAPAN , 20 years of age, was diagnosed with alopecia areata and was treated with Kenacort (View Usage). Patient had the following side effects: lichen planus, lichen striatus. Kenacort dosage: .

6035442-4 | Iron Deficiency Anaemia, Paralysis
on Jan 07, 2009 Male patient from JAPAN , 17 years of age, was diagnosed with carpal tunnel syndrome (What is carpal tunnel syndrome?) and was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: iron deficiency anaemia, paralysis (What is paralysis?). Kenacort dosage: .

6019540-7 | Alopecia, Erythema, Facial Pain, Fatigue, Gastritis Erosive, Injection Site Atrophy, Muscular Weakness, Onychoclasis
Patient was taking Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, erythema, facial pain, fatigue, gastritis erosive, injection site atrophy, muscular weakness, onychoclasis on Dec 19, 2008 from FRANCE Additional patient health information: Female patient , 61 years of age, weighting 116.8 lb, . Kenacort dosage: Received Second Inj Diluted At 50% On 26-jun-2007.

6017149-2 | Haemarthrosis
Adverse event was reported on Dec 17, 2008 by a Male patient taking Kenacort (View Usage) (Dosage: Received Once) was diagnosed with joint effusion and. Location: JAPAN , 68 years of age, Patient had the following side effects: haemarthrosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ARTZ (View Artz Review and Artz Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TANATRIL (View Tanatril Review and Tanatril Label ), FLIVAS (View Flivas Review and Flivas Label ). Patient was hospitalized.

6010360-6 | Gastrointestinal Perforation
on Dec 15, 2008 Female patient from JAPAN , 61 years of age, was diagnosed with malignant ascites and was treated with Kenacort (View Usage). After Kenacort was administered, patient had the following side effects: gastrointestinal perforation. Kenacort dosage: .

6010172-3 | Chorioretinopathy
on Dec 15, 2008 Female patient from JAPAN , 59 years of age, was diagnosed with macular oedema and was treated with Kenacort (View Usage). Patient experienced the following unwanted or unexpected effects: chorioretinopathy. Kenacort dosage: 1df=40mg/ml. Intravitreal Route.

5993070-0 | Haemarthrosis
Patient was taking Kenacort (View Usage). Patient had the following side effects: haemarthrosis on Dec 08, 2008 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with joint effusion and. Kenacort dosage: Received Once. During the same period patient was treated with ARTZ (View Artz Review and Artz Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TANATRIL (View Tanatril Review and Tanatril Label ), FLIVAS (View Flivas Review and Flivas Label ). Patient was hospitalized.